Solution-focused group therapy for level 1 substance abusers.

The present study compared solution-focused group therapy (SFGT) with a traditional problem-focused treatment for level 1 substance abusers. Outcome research on the effectiveness of solution-focused group therapy is minimal, especially in treating substance abusers. In the present study, clients were measured before and after treatment to determine therapeutic effectiveness. Clients in the solution-focused group significantly improved on both the Beck Depression Inventory and the Outcome Questionnaire. The clients in the comparison group did not improve significantly on either measure. Therapist skill level and adherence to theoretical models were measured in each group to reduce confounding variables.

Steve de Shazer and the future of solution-focused therapy.

Steve de Shazer who, along with Insoo Kim Berg, co-founded the Solution-Focused Brief Therapy (SFBT) approach, recently passed away. In this article we will offer a brief biographical sketch and then discuss the current state of the art of SFBT as it applies to practice, training, and research. Future directions for SFBT, such as the emergence of professional associations, the increased research interest in SFBT as evidenced-based practice, the recent focus on process-research to determine the mechanisms of change within SFBT, and the application of SFBT to education are discussed.

Partner relationship quality and drug use as predictors of women's substance abuse treatment outcome.

This study examined the relationship of relationship quality and partner's drug use on treatment outcomes for women in outpatient drug treatment. The sample consisted of predominately heterosexual couples where the female partner was in drug treatment. Both the partners' perception of relationship quality and the interaction of female client and her partner's perception of relationship quality were significant predictors of one of the outcome variables-the client's posttest report of days of drug use during the previous 30 days. Interestingly, clients reported more days of drug use when their partners reported higher relationship quality. A similar pattern was found with the ASI Drug composite score as the dependent variable except that the interaction term was not significant in that analysis. In addition, partners' relationship quality scores were associated with female clients' treatment completion. A higher proportion of women whose partners reported higher relationship quality failed to complete treatment. Partners' reports of pretest and posttest drug use were not related to women's treatment outcomes.